photosensitivity disease: Photosensitivity refers to various symptoms, diseases and conditions caused or aggravated by exposure to sunlight.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
287 |
4. Check minimum number of eventsNone |
287 |
5. Include endpointsNone |
287 |
6. Filter based on genotype QC (FinnGen only) |
280 |
Control definitions (FinnGen only)
- Control exclude
- L12_RADIATIONRELATEDSKIN
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L56
- Name in latin
- Eruptio polymorpha solaris
Similar endpoints
↥List of similar endpoints to
Polymorphous light eruption
based on the number of shared cases.
Similar with more cases:
- Other acute skin changes due to ultraviolet radiation
- Radiation-related disorders of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1773 | 1252 | 515 |
| Only index persons | 1610 | 1179 | 431 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.01 |
| Only index persons | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 42.81 | 41.90 | 45.06 |
| Only index persons | 42.03 | 41.75 | 42.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 280 | 230 | 50 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.02 |
| Median age at first event (years) | 45.45 | 43.94 | 52.37 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 287
- Matched controls
- 2870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L56.4
ICD-10 Finland
Polymorphous light eruption
12169.0
307.7
275
*
XQ802
NOMESCO Finland
Epicutan test
14.1
66.7
68
62
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
7.0
47.3
90
176
D07AB08
ATC
desonide; topical
6.8
46.2
91
184
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.7
45.4
126
349
P01BA02
ATC
hydroxychloroquine; oral
6.8
42.4
80
154
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.0
40.1
62
96
E0000UV, ,
ATC
4.3
31.4
186
866
E000001, ,
ATC
4.4
30.9
111
362
D07AB02
ATC
hydrocortisone butyrate; topical
3.9
29.0
144
586
D07AA02
ATC
hydrocortisone; topical
4.3
26.6
89
272
H02AB06
ATC
prednisolone; systemic
3.8
26.1
191
983
D07AC01
ATC
betamethasone; topical
3.6
25.7
156
711
D07AC13
ATC
mometasone; topical
3.5
23.8
130
548
XQ800
NOMESCO Finland
Prick test
4.9
21.3
53
127
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
7.5
18.6
28
41
E000002, ,
ATC
3.7
17.0
63
202
6927F
ICD-9 Finland
Contact dermatitis and other eczema, Due to solar radiation[ERUPTIO POLYMORPHICA SOLARIS]
+∞
16.8
16
*
R06AE07
ATC
cetirizine; oral
2.9
16.7
177
1031
R06AX27
ATC
desloratadine; oral
2.8
15.9
132
673
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.5
15.8
64
217
L56.3
ICD-10 Finland
Solar urticaria
168.8
15.6
16
*
L20.0
ICD-10 Finland
Besnier prurigo
4.0
15.5
50
145
R06AE09
ATC
levocetirizine; oral
3.2
15.5
76
290
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
21.5
15.4
22
11
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
5.6
14.2
28
54
L93.0
ICD-10 Finland
Discoid lupus erythematosus
31.9
14.1
18
6
D07BC01
ATC
betamethasone and antiseptics; topical
3.3
12.5
52
178
D02AE01
ATC
carbamide; topical
4.6
12.3
31
74
R06AX22
ATC
ebastine; oral
2.7
12.3
83
373
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
4.7
11.5
28
65
D07AD01
ATC
clobetasol; topical
2.7
10.7
68
294
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
+∞
10.5
10
*
D02AX
ATC
Other emollients and protectives
5.6
10.3
20
38
E000007, ,
ATC
3.9
10.1
31
86
L04AX03
ATC
methotrexate; systemic
3.1
9.8
45
163
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
10.6
9.7
18
18
L56.9
ICD-10 Finland
Acute skin change due to ultraviolet radiation, unspecified
103.3
9.5
10
*
XQ806
NOMESCO Finland
Minimal Erythema Dose (MED) test
+∞
9.4
9
*
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
+∞
9.4
9
*
L50.3
ICD-10 Finland
Dermatographic urticaria
7.7
9.4
21
29
L30.3
ICD-10 Finland
Infective dermatitis
4.5
9.1
23
55
E000003, ,
ATC
4.1
8.9
25
65
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
8.5
69
334
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
7.9
8.3
18
24
M25.5
ICD-10 Finland
Pain in joint
2.1
8.1
120
739
TQW80
NOMESCO Finland
Local dermatologic skincare
8.4
7.7
16
20
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.8
7.5
39
151
R06AX13
ATC
loratadine; oral
2.3
7.4
64
316
D07AC14
ATC
methylprednisolone aceponate; topical
3.7
7.4
24
69
D07AB01
ATC
clobetasone; topical
4.5
7.3
18
42
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
14.2
6.9
11
8
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
9.7
6.9
13
14
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.1
6.8
19
49
D02BB01
ATC
betacarotene; oral
23.1
6.7
9
*
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
12.6
6.6
11
9
N05BB01
ATC
hydroxyzine; systemic
3.0
6.4
30
109
L08
ICPC
Shoulder symptom/complaint
2.1
6.4
70
379
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
6.4
72
395
XQ848
NOMESCO Finland
Dermatological photography
5.6
6.3
17
32
J01MA14
ATC
moxifloxacin; systemic
2.8
6.1
31
118
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
10.3
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
62
4.51
10.33
1.3
1.3
8.54
1.04
u/ml
—
5
5
30
81
4.02
10.16
1.4
1.3
2.17
7.66
u/ml
—
9
18
30
81
4.02
10.16
1.4
1.3
1.87
3.44
u/ml
—
8
11
25
69
3.87
8.21
1.2
1.2
51.21
42.27
u/ml
—
8
7
31
100
3.35
8.10
2.5
2.2
—
—
—
0
0
81
485
1.93
5.56
1.4
1.3
2.48
9.96
u/ml
2.34
29
211
141
1021
1.75
5.12
2.4
2.2
80.61
76.05
nmol/l
0.98
131
933
153
1153
1.70
4.66
7.4
5.3
28.37
29.30
%
0.67
148
1091
151
1144
1.68
4.43
6.9
5.2
57.12
56.70
%
0.20
146
1080
77
495
1.76
4.09
1.5
1.3
41.56
32.97
iu/ml
0.22
29
177
214
1801
1.74
4.03
5.7
3.9
12.19
10.00
mm/h
1.72
203
1688
67
419
1.78
3.89
1.4
2.0
—
—
—
0
0
60
374
1.76
3.50
1.3
1.9
—
—
—
0
0
10
23
4.47
3.34
1.3
1.0
—
—
—
0
0
88
626
1.59
3.08
1.3
1.3
0.99
1.53
u/ml
0.56
18
179
168
1379
1.53
3.06
9.8
8.9
3.95
3.96
e9/l
0.02
152
1212
131
1022
1.52
3.02
5.2
5.4
1.23
1.22
mmol/l
0.48
103
876
121
930
1.52
2.98
3.8
4.9
1.23
1.22
mmol/l
0.66
113
858
14
298
0.44
2.39
1.2
1.6
—
—
—
0
0
12
46
2.68
2.39
2.3
1.3
—
—
—
0
0
50
329
1.63
2.38
1.9
1.6
991.92
1193.73
nmol/l
0.97
41
246
85
632
1.49
2.37
1.8
1.7
1.48
1.36
mmol/l
0.45
77
557
8
23
3.55
2.28
1.4
1.1
—
—
—
0
0
8
23
3.55
2.28
1.4
1.1
—
—
—
0
0
74
541
1.50
2.22
2.3
2.0
2.63
2.95
mg/l
0.71
66
464
5
9
5.63
2.22
1.8
3.8
362.80
748.00
u/ml
—
5
9
140
1155
1.41
2.21
3.5
3.2
0.00
0.00
estimate
-0.00
29
241
8
24
3.40
2.19
1.4
1.1
—
—
—
0
0
8
24
3.40
2.19
1.4
1.1
—
—
—
0
0
8
24
3.40
2.19
1.4
1.1
—
—
—
0
0
79
588
1.47
2.17
1.5
1.6
—
—
—
0
0
140
1158
1.41
2.17
4.7
4.5
0.00
0.00
estimate
-0.00
29
227
14
63
2.28
2.04
2.1
2.4
10.32
11.29
mg/l
0.22
14
58
11
44
2.56
2.03
1.1
1.1
—
—
—
0
0
140
1167
1.39
2.03
3.4
3.2
0.00
0.03
estimate
0.80
29
221
40
262
1.61
1.95
1.7
2.2
22.53
23.48
%
0.22
35
232
257
2407
1.65
1.84
12.5
11.5
3.93
3.93
mmol/l
0.06
250
2336
218
1975
1.43
1.83
4.2
4.3
14.54
14.44
pmol/l
0.26
207
1835
5
12
4.22
1.83
2.6
3.1
36320.00
38308.33
ug/l
—
5
12
51
361
1.50
1.78
3.1
3.2
16.10
472.84
ng/l
1.47
30
230
9
36
2.55
1.75
4.3
3.5
54.00
58.78
%
—
9
36
79
612
1.40
1.72
3.6
3.5
0.00
0.00
estimate
0.50
29
229
104
844
1.36
1.71
1.9
1.9
96.54
95.21
pmol/l
0.08
57
450
137
1164
1.34
1.66
4.0
5.3
9.24
9.81
umol/l
0.57
132
1108
198
1786
1.35
1.55
7.4
6.5
71.27
74.83
u/l
1.06
190
1683
90
725
1.35
1.53
2.7
3.0
2.36
2.36
mmol/l
0.01
77
654
254
2401
1.50
1.40
12.6
11.5
139.63
139.76
mmol/l
0.36
248
2336
6
23
2.64
1.37
1.7
1.2
—
—
—
0
0
6
131
0.45
1.32
1.5
1.4
—
—
—
0
0
244
2296
1.42
1.31
5.2
4.9
1.87
1.78
mu/l
0.52
232
2151
53
402
1.39
1.30
2.0
1.6
180435182.96
13928019.18
pmol/l
0.44
46
359
256
2432
1.49
1.28
13.0
11.0
14.90
20.02
mg/l
2.86
208
1862
108
914
1.29
1.27
3.5
3.2
—
—
—
0
0
20
124
1.66
1.24
1.3
1.4
—
—
—
0
0
18
111
1.66
1.15
2.1
2.1
46.17
39.98
u/l
0.42
18
101
21
135
1.60
1.15
1.8
2.2
1102.18
3651.93
u/l
—
6
55
138
1217
1.26
1.13
3.2
2.7
87.78
80.43
ug/l
0.27
131
1151
12
67
1.83
1.06
1.7
1.7
—
0.07
—
0
10
13
75
1.77
1.04
1.8
1.3
—
—
—
0
0
29
206
1.45
1.03
2.6
2.3
—
18.25
—
0
13
5
109
0.45
1.03
1.6
3.2
0.15
0.10
e6/l
—
5
104
63
511
1.30
1.01
3.4
3.4
1.02
1.02
kg/l
0.31
13
74
7
35
2.02
1.00
1.4
1.5
—
—
—
0
0
11
186
0.58
1.00
2.5
2.3
20.27
26.87
u/ml
0.42
11
174
16
100
1.64
0.99
1.8
1.9
—
—
—
0
0
139
1248
1.22
0.91
3.4
3.9
6.25
6.36
mmol/l
0.26
130
1128
238
2266
1.29
0.88
11.2
9.8
89.06
87.33
ml/min/173m2
0.68
187
1845
8
47
1.72
0.81
1.3
2.2
—
—
—
0
0
45
360
1.30
0.81
2.6
2.6
2.45
2.44
mmol/l
0.24
34
315
7
123
0.56
0.80
1.3
1.4
—
—
—
0
0
7
123
0.56
0.80
1.3
1.4
—
—
—
0
0
7
124
0.55
0.79
1.3
1.4
—
—
—
0
0
7
124
0.55
0.79
1.3
1.4
—
—
—
0
0
6
33
1.84
0.79
1.0
1.5
—
—
—
0
0
6
33
1.84
0.79
1.2
1.5
—
—
—
0
0
6
33
1.84
0.79
1.2
1.5
—
—
—
0
0
6
33
1.84
0.79
1.2
1.5
—
—
—
0
0
8
48
1.69
0.79
2.4
1.6
—
—
—
0
0
65
547
1.24
0.78
3.0
2.5
315.07
5001.41
umol/l
2.01
57
492
21
149
1.44
0.78
1.0
1.0
—
—
—
0
0
6
34
1.78
0.76
1.2
1.5
—
—
—
0
0
6
34
1.78
0.76
1.2
1.5
—
—
—
0
0
12
75
1.63
0.76
1.2
1.1
—
—
—
0
0
8
132
0.59
0.75
1.3
1.5
—
—
—
0
0
7
38
1.86
0.74
1.0
1.3
—
—
—
0
0
100
892
1.19
0.67
9.9
9.0
1.16
1.14
inr
0.10
37
273
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
15
104
1.47
0.64
1.9
1.6
—
—
—
0
0
25
191
1.34
0.63
1.8
2.8
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
39
320
1.25
0.60
2.1
1.7
1.67
1.33
%
1.90
33
288
66
573
1.20
0.60
3.5
3.5
1.46
9.54
mg/mmol
4.56
42
340
263
2566
1.30
0.55
11.6
9.1
24.45
24.72
u/l
0.13
256
2494
9
60
1.52
0.55
1.3
1.2
—
—
—
0
0
56
644
0.84
0.54
1.4
1.5
—
—
—
0
0
55
475
1.20
0.53
1.5
1.4
20.02
22.38
nmol/l
0.51
48
410
9
63
1.44
0.53
1.3
1.2
3.58
3.66
mmol/l
—
9
56
28
227
1.26
0.49
2.7
4.2
21.99
22.40
%
—
9
101
223
2301
0.86
0.45
3.8
3.6
1.33
1.24
mmol/l
0.95
210
2168
85
773
1.14
0.44
2.3
2.9
—
—
—
0
0
190
1818
1.13
0.43
3.9
3.7
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
16
206
0.76
0.43
1.1
1.5
—
—
—
0
0
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
104
1119
0.89
0.40
2.8
2.3
—
—
—
0
0
20
247
0.80
0.40
2.0
1.7
—
—
—
0
0
24
197
1.24
0.39
1.8
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
9
70
1.29
0.37
1.6
1.3
318.89
391.68
mg/l
—
9
65
35
302
1.18
0.36
1.8
1.8
—
—
—
0
0
5
80
0.62
0.36
3.6
3.2
43.22
51.65
%
—
5
80
94
872
1.12
0.35
4.4
3.9
36.75
36.64
g/l
0.09
82
828
6
43
1.40
0.35
1.5
1.6
—
—
—
0
0
14
177
0.78
0.34
8.6
2.1
76.14
74.87
ml/min/173m2
—
7
77
38
333
1.16
0.33
2.3
2.6
0.98
0.93
e6/l
0.04
17
174
12
92
1.32
0.32
2.3
1.6
—
—
—
0
0
23
193
1.21
0.32
1.9
1.7
—
—
—
0
0
12
153
0.77
0.31
1.5
1.4
—
—
—
0
0
65
595
1.12
0.31
2.7
2.7
0.29
0.45
e6/l
0.37
49
432
220
2145
1.11
0.28
5.1
4.8
38.78
38.59
mmol/mol
0.10
201
2034
10
76
1.33
0.28
1.3
1.3
—
—
—
0
0
50
549
0.89
0.27
1.8
1.7
1.33
0.84
mg/l
0.27
39
420
8
65
1.24
0.27
2.1
1.5
—
—
—
0
0
52
475
1.12
0.26
2.2
2.9
593.02
841.77
ng/l
0.65
43
404
274
2711
1.24
0.25
20.3
16.9
267.15
261.07
e9/l
0.91
263
2657
274
2712
1.23
0.24
20.2
16.8
40.92
40.14
%
2.96
255
2571
234
2382
0.90
0.23
4.2
4.0
1.47
1.53
mmol/l
1.59
216
2259
274
2714
1.21
0.22
20.3
16.9
4.53
4.48
e12/l
1.22
263
2661
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
26.08
—
0
11
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.0
—
141.90
—
0
10
0
10
0.00
0.21
0.0
1.0
—
2147.00
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
167.92
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
8.59
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
106.31
—
0
13
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
274
2715
1.20
0.20
20.3
17.0
135.91
134.42
g/l
1.30
269
2681
16
184
0.86
0.17
2.1
1.6
—
—
—
0
0
10
120
0.83
0.17
1.4
1.8
—
—
—
0
0
8
70
1.15
0.16
1.1
1.1
—
—
—
0
0
9
81
1.11
0.15
1.4
1.6
—
—
—
0
0
26
238
1.10
0.13
1.4
1.3
141.95
188.26
iu/ml
0.34
11
109
10
87
1.15
0.09
1.7
2.2
1.69
1.29
%
—
10
87
6
56
1.07
0.08
1.2
1.5
—
—
—
0
0
6
58
1.04
0.08
1.5
1.5
0.29
0.33
nmol/l
—
6
45
23
246
0.93
0.08
3.1
5.5
—
—
—
0
0
17
156
1.10
0.08
2.5
3.0
1.67
2.31
mmol/l
0.32
17
121
7
67
1.05
0.08
1.0
1.5
—
—
—
0
0
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
232
2301
1.04
0.07
4.3
4.0
5.77
5.77
mmol/l
0.02
214
2163
9
88
1.02
0.07
1.6
1.9
—
—
—
0
0
33
315
1.05
0.06
2.3
2.8
1.54
3.36
e6/l
1.61
13
156
19
203
0.93
0.06
5.7
5.6
105.42
104.72
mmol/l
0.27
19
203
238
2394
0.97
0.05
4.3
4.0
4.73
4.83
mmol/l
0.73
222
2276
171
1725
0.98
0.04
3.2
2.9
36.55
38.18
u/l
0.16
164
1639
12
111
1.08
0.04
1.0
1.3
—
—
—
0
0
13
121
1.08
0.04
1.3
1.3
348.29
261.90
miu/ml
—
5
61
241
2421
0.97
0.03
4.8
4.4
2.85
2.88
mmol/l
0.17
222
2294
18
172
1.05
0.02
2.2
2.8
0.55
0.89
ug/l
—
9
108
12
127
0.94
0.01
1.2
1.5
—
—
—
0
0
26
259
1.00
0.00
3.8
4.1
31.19
32.27
%
0.20
21
184
78
777
1.01
0.00
2.6
3.0
12.30
24.48
ng/l
2.01
43
432
54
536
1.01
0.00
2.6
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
1.20
—
0
6
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
9
94
0.96
-0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.5
—
219.88
—
0
8
8
82
0.97
-0.00
1.6
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_POLYMORPHLIGHTERUPT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_POLYMORPHLIGHTERUPT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_POLYMORPHLIGHTERUPT – Polymorphous light eruption
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data